Disclosed microreactors operate in an electrical discharge mode, such as a pulse mode, an arc mode or a corona discharge mode, and most preferably in a corona discharge mode. A microreactor may comprise multiple, simultaneously operating corona discharges. The microreactor typically has at least one feature measured on a millimeter scale. Certain disclosed microreactors comprised multiple reactor plates in a stack. Each plate comprised plural corona discharge electrodes positioned in series along each of plural corresponding microchannels. A method for using disclosed microreactors and systems comprising disclosed microreactors, such as for chemical transformations, fluid purifications, or both, also is disclosed.

The present invention provides microfabricated substrates and methods of conducting reactions within these substrates. The reactions occur in plugs transported in the flow of a carrier-fluid.

The present invention provides microfabricated substrates and methods of conducting reactions within these substrates. The reactions occur in plugs transported in the flow of a carrier-fluid.

A flow reactor system and methods having tubing useful as polymerization chamber. The flow reactor has at least one inlet and at least one mixing chamber, and an outlet. The method includes providing two phases, an aqueous phase and a non-aqueous phase and forming an emulsion for introduction into the flow reactor.

The invention generally relates to assemblies for displacing droplets from a vessel that facilitate the collection and transfer of the droplets while minimizing sample loss. In certain aspects, the assembly includes at least one droplet formation module, in which the module is configured to form droplets surrounded by an immiscible fluid. The assembly also includes at least one chamber including an outlet, in which the chamber is configured to receive droplets and an immiscible fluid, and in which the outlet is configured to receive substantially only droplets. The assembly further includes a channel, configured such that the droplet formation module and the chamber are in fluid communication with each other via the channel. In other aspects, the assembly includes a plurality of hollow members, in which the hollow members are channels and in which the members are configured to interact with a vessel. The plurality of hollow members includes a first member configured to expel a fluid immiscible with droplets in the vessel and a second member configured to substantially only droplets from the vessel. The assembly also includes a main channel, in which the second member is in fluid communication with the main channel. The assembly also includes at least one analysis module connected to the main channel.

The present invention relates to a microfluidic flow process for making polymers, polymers made by such processes, and methods of using such polymers. In such process, a novel reagent delivery setup is used in conjunction with microfluidic reaction technology to synthesize anionic polymerization reaction products from superheated monomer orders of magnitude faster than is possible in batch and continuous syntheses. The aforementioned process does not require the cryogenic temperatures which are required for such syntheses in batch or bulk continuous. Thus the aforementioned process is more economically efficient and reduces the environmental impact of linear polymer production.

This disclosure provides systems and methods for the production of formulations of active pharmaceutical ingredients (APIs). In some embodiments, the disclosure provides an automated medicine formulation system comprising a portable and self-contained API formulating apparatus where the API and excipients are formulated to make a drug product meeting drug quality and safety specifications. The automated formulation system produces liquid formulations including, for example, injectable and intravenous medicines. The systems are capable of producing a plurality of individual sterile injectable doses of drug comprising a specific API and excipient(s), which can be formulated on demand in a GMP and FDA acceptable manner.

The present disclosure is directed towards improved systems and methods for large-scale production of nanoparticles used for delivery of therapeutic material. The apparatus can be used to manufacture a wide array of nanoparticles containing therapeutic material including, but not limited to, lipid nanoparticles and polymer nanoparticles. In certain embodiments, continuous flow operation and parallelization of microfluidic mixers contribute to increased nanoparticle production volume.

A chemical reactor and method for operation. The reactor enables N pairwise fluid contacts among k chemical fluids, with k2 and N4 and comprises: a reaction layer extending in a plane subtended by two directions; N chemical cells, each including two circuit portions, designed for enabling circulation of two of the k chemical fluids, respectively, the two circuit portions intersecting each other, thereby enabling one pairwise fluid contact for the two of the k chemical fluids; and a fluid distribution circuit comprising: k sets of inlet orifices sequentially alternating along lines parallel to one of the two directions, for respectively dispensing k chemical fluids to the reaction layer; and k sets of outlet orifices sequentially alternating along lines parallel to the inlet orifices, for respectively collecting k chemical fluids from the reaction layer, and wherein, each circuit portion connects an inlet orifice to an outlet orifice.

A process for producing an alkylene oxide adduct can continuously produce the alkylene oxide adduct by using a microflow reactor having a tubular flow passage and a micromixer connected to a supply port of the microflow reactor. Liquid state alkylene oxide, alkylene catalyst and an organic compound having an active hydrogen atom(s) are reacted while passing therethrough under the conditions of a temperature of the flow passage of 70 to 200 C. and a pressure of the supply port of the flow passage of 1 to 10 MPa.